Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Vitorino

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Genes & Development|December 6, 2008
Modular control of endothelial sheet migrationPhilip Vitorino, Tobias Meyer
Molecular and Cellular Biology|October 27, 2010
A steering model of endothelial sheet migration recapitulates monolayer integrity and directed collective migrationPhilip Vitorino, Mark Hammer, Jongmin Kim, et al.
Translational Oncology|October 19, 2020
Rova-T enhances the anti-tumor activity of anti-PD1 in a murine model of small cell lung cancer with endogenous Dll3 expressionPhilip Vitorino, Chen-Hua Chuang, Alexandre Iannello, et al.
Nature|March 25, 2015
MAP4K4 regulates integrin-FERM binding to control endothelial cell motilityPhilip Vitorino, Stacey Yeung, Ailey Crow, et al.
Molecular Cancer Therapeutics|June 1, 2022
ABBV-011, A Novel, Calicheamicin-Based Antibody-Drug Conjugate, Targets SEZ6 to Eradicate Small Cell Lung Cancer TumorsWolf R Wiedemeyer, Julia Gavrilyuk, Alexander Schammel, et al.
Blood|July 27, 2013
Rasip1 regulates vertebrate vascular endothelial junction stability through Epac1-Rap1 signalingChristopher W Wilson, Leon H Parker, Christopher J Hall, et al.
Journal of Medicinal Chemistry|March 29, 2014
Discovery of selective 4-Amino-pyridopyrimidine inhibitors of MAP4K4 using fragment-based lead identification and optimizationTerry D Crawford, Chudi O Ndubaku, Huifen Chen, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Structure-Based Design of GNE-495, a Potent and Selective MAP4K4 Inhibitor with Efficacy in Retinal AngiogenesisChudi O Ndubaku, Terry D Crawford, Huifen Chen, et al.
Scientific Reports|November 19, 2025
BIGH3 is a mediator of TGFβ-Induced collagen formation in fibrosis and pancreatic cancer and a potential therapeutic targetNicholas Willumsen, Kim Henriksen, Cecilie Bager, et al.
Neoplasia (New York, N.Y.)|July 2, 2013
Multimodal microvascular imaging reveals that selective inhibition of class I PI3K is sufficient to induce an antivascular responseDeepak Sampath, Jason Oeh, Shelby K Wyatt, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Genes & Development|December 6, 2008
Modular control of endothelial sheet migrationPhilip Vitorino, Tobias Meyer
Molecular and Cellular Biology|October 27, 2010
A steering model of endothelial sheet migration recapitulates monolayer integrity and directed collective migrationPhilip Vitorino, Mark Hammer, Jongmin Kim, et al.
Translational Oncology|October 19, 2020
Rova-T enhances the anti-tumor activity of anti-PD1 in a murine model of small cell lung cancer with endogenous Dll3 expressionPhilip Vitorino, Chen-Hua Chuang, Alexandre Iannello, et al.
Nature|March 25, 2015
MAP4K4 regulates integrin-FERM binding to control endothelial cell motilityPhilip Vitorino, Stacey Yeung, Ailey Crow, et al.
Molecular Cancer Therapeutics|June 1, 2022
ABBV-011, A Novel, Calicheamicin-Based Antibody-Drug Conjugate, Targets SEZ6 to Eradicate Small Cell Lung Cancer TumorsWolf R Wiedemeyer, Julia Gavrilyuk, Alexander Schammel, et al.
Blood|July 27, 2013
Rasip1 regulates vertebrate vascular endothelial junction stability through Epac1-Rap1 signalingChristopher W Wilson, Leon H Parker, Christopher J Hall, et al.
Journal of Medicinal Chemistry|March 29, 2014
Discovery of selective 4-Amino-pyridopyrimidine inhibitors of MAP4K4 using fragment-based lead identification and optimizationTerry D Crawford, Chudi O Ndubaku, Huifen Chen, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Structure-Based Design of GNE-495, a Potent and Selective MAP4K4 Inhibitor with Efficacy in Retinal AngiogenesisChudi O Ndubaku, Terry D Crawford, Huifen Chen, et al.
Scientific Reports|November 19, 2025
BIGH3 is a mediator of TGFβ-Induced collagen formation in fibrosis and pancreatic cancer and a potential therapeutic targetNicholas Willumsen, Kim Henriksen, Cecilie Bager, et al.
Neoplasia (New York, N.Y.)|July 2, 2013
Multimodal microvascular imaging reveals that selective inhibition of class I PI3K is sufficient to induce an antivascular responseDeepak Sampath, Jason Oeh, Shelby K Wyatt, et al.
Pageof 1